WeVote

Bill

Bill

SR 112

Relative to Familial Adenomatous Polyposis Awareness Week.

2025-2026 Regular Session Introduced by Roger Niello

Designates a specific week in California as FAP Awareness Week to promote education on familial adenomatous polyposis, screening, and resources.

Read. Adopted. (Ayes 36. Noes 0.)
0
WeVote Research Nonpartisan
Bill Summary · SR 112

Summary of SR 112 (2025-2026) – Relative to Familial Adenomatous Polyposis Awareness Week

Purpose and intent

  • SR 112 designates a statewide recognition in California by establishing a Familial Adenomatous Polyposis (FAP) Awareness Week. The resolution aims to raise awareness about FAP, a hereditary condition that increases the risk of colorectal cancer and related cancers.
  • By naming a specific Awareness Week, the measure seeks to inform the public, patients, families, and healthcare providers about FAP, its genetic nature, screening options, and available resources.

Key provisions

  • Proclamation/Recognition: The resolution requests the Senate (and typically the Assembly as well, if mirrored in companion measures) to formally recognize a designated week as FAP Awareness Week within California.
  • Purposeful causes: Encourages education about FAP symptoms, early detection through genetic testing and colonoscopic surveillance, and the importance of timely medical follow-up.
  • Stakeholder engagement: Invites coordination with medical professionals, patient advocacy groups, and public health entities to disseminate information during the designated week.

Who or what would be affected

  • The primary effect is symbolic and educational: state government recognition to promote awareness of FAP.
  • No new mandates, funding allocations, or regulatory requirements are created by the resolution itself.
  • The measure may influence public health communications and outreach activities during the designated week.

Procedural and timeline aspects

  • Introduction and referrals: Initially referred to the Senate Rules Committee (RLS) after introduction.
  • Amendments: In May 2026, the committee reported the measure with the author’s amendments and then re-referred to RLS, indicating adjustments were considered prior to final passage.
  • Passage status: As of the latest action, the resolution is moving toward third reading after committee review, suggesting eventual floor consideration if no further amendments arise.
  • Sponsorship: Co-sponsor listed—Roger Niello—indicating support from at least one additional legislator.

Potential impact and considerations

  • Public awareness: When enacted, SR 112 could heighten statewide knowledge about FAP and the importance of genetic counseling and regular screening for at-risk individuals.
  • Public health synergy: The resolution could complement ongoing colorectal cancer prevention efforts and hereditary cancer education by providing a formal, recognized timeframe for outreach.
  • Limitations: The measure does not create funding, impose requirements, or mandate specific programs; its impact relies on concurrent education and advocacy by public health partners and organizations.

If you’d like, I can compare SR 112 to similar awareness designations in other states or provide a brief overview of Familial Adenomatous Polyposis and standard screening guidelines to add context.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.